QA: Tempest Therapeutics Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001544227_2018_Tempest_Therapeutics_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001544227, Tempest Therapeutics Inc.

  xvar xval
0 AssetsCurrent 68,781,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,113,000
3 remainder_Assets 959,000
4 LiabilitiesCurrent 7,804,000
5 LiabilitiesNoncurrent 751,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 790,000
8 SellingGeneralAndAdministrativeExpense 27,744,000
9 ResearchAndDevelopmentExpense 18,337,000
10 remainder_Expenses 4,097,000
11 remainder_Revenues 295,000
12 remainder_NetIncome -302,000
13 remainder_ComprehensiveNetIncome 33,000
  yvar yval
0 Assets 72,853,000
1 Liabilities 8,555,000
2 Expenses 50,968,000
3 Revenues 295,000
4 StockholdersEquity 64,298,000
5 NetIncome -50,975,000
6 ComprehensiveNetIncome -50,958,500
7 BaseVar 66,503,000
8 EconomicCapitalRatio 1.47

Edgar->Model Mapping

Feature Distribution

Change over Time